Sarbajit Mukherjee, MD, MS
Sarbajit Mukherjee, MD, MS
Biography
Oncology is one of the most academic disciplines of medicine, and its scientific concepts are rapidly evolving. Over the past few years, a convergence of innovations has created an unprecedented opportunity for us to make a big impact on cancer. Working at a top-notch institution like Roswell Park Comprehensive Cancer Center allows me to integrate those cutting age innovations into the day-to-day care of my patients. I hope to see a day when cancer, stripped of its intimidation, will be "a word, not a sentence."
Background
1. Wang Z, Aguilar EG, Luna JI, Dunai C, Khuat LT, Le CT, Mirsoian A,Minnar CM, Stoffel KM, Sturgill IR, Grossenbacher SK, Withers SS, Rebhun RB, Hartigan-O’Connor DJ, Méndez-Lagares G, Tarantal AF, Isseroff RR, Griffith TS, Schalper KA, Merleev A, Saha A, Maverakis E, Kelly K, Aljumaily R, Ibrahimi S, Mukherjee S, Machiorlatti M, Vesely SK, Longo DL, Blazar BR, Canter RJ, Murphy WJ, Monjazeb AM. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade. In-Press. Nature Medicine.
2. Samuel S, Mukherjee S, Ammannagari N, Pokuri VK, Kuvshinoff B, Groman A, LeVea CM, Iyer R. Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study. PLoS One. 2018 Jun 11;13(6):e0198809. PubMed PMID: 29889907.
3. Mukherjee S, Ibrahimi S, Khalid B, Roman D, Zhao D, Aljumaily R. Do proton pump inhibitors modulate the efficacy of anti-PD-1/PD-L1 therapy? A retrospective study. J Oncol Pharm Pract. 2018 Jan 1:1078155218771152. PubMed PMID: 29690815.
4. Mukherjee S, Ibrahimi S, John S, Adnan MM, Scordino T, Khalil MO, Cherry M. Non-seminomatous mediastinal germ cell tumor and acute megakaryoblastic leukemia. Ann Hematol. 2017 Sep; 96(9):1435-1439. PubMed PMID: 28578457.
5. Mukherjee S, Ibrahimi S, Machiorlatti M, Roman D, Saleem R, Hassan A, Baxley A, Vesely S, Aljumaily R. Personalized Dosing Versus Fixed Dosing of Immune Checkpoint Inhibitors: A Cost Analysis Study. Am J Ther. 2018 May 1. PubMed PMID: 29746291.